Managed Healthcare Executive

ENA respiratory launches phase 2 community study of INNA-051 nasal spray

The company noted that its Phase 2 community study, known as POSITS, has started with the first participants being dosed in ...
Medical Xpress

Co-development of gut microbiome, respiratory and immune systems directly impact baby's development

A new multidisciplinary study conducted by researchers at the University of Rochester Medical Center has found that the co-development of three systems, the gut microbiome, respiratory system and ...
News Medical

Co-development of three systems linked with baby's respiratory health

A new multidisciplinary study conducted by researchers at the University of Rochester Medical Center has found that the co-development of three systems, the gut microbiome, respiratory system and ...
Business Insider

ENA Respiratory Attracts US$22.4m (AU$34m) to Fund Phase II Development of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections

MELBOURNE, Australia, Oct. 22, 2025 (GLOBE NEWSWIRE) -- ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defense enhancers to minimize the impact of symptomatic viral ...
Nasdaq

Eagle Pharmaceuticals Takes Equity Stake in, with Option to Acquire, Enalare Therapeutics to Advance Global Development of ENA-001, a Novel Agnostic Respiratory Stimulant

-- ENA-001 is currently in development for: post-operative respiratory depression, community drug overdose, and Apnea of Prematurity -- -- Approval for post-operative respiratory depression expected ...
Healio

Coughs, wheezes and sneezes: Distinguishing pediatric respiratory infections

Respiratory infections are the leading causes of hospitalizations, ED visits and mortality in children in the United States ...